{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:02:23Z","timestamp":1793822543534,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1810650"],"award-info":[{"award-number":["W81XWH1810650"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41375-023-01911-2","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T15:02:25Z","timestamp":1682694145000},"page":"1485-1498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma"],"prefix":"10.1038","volume":"37","author":[{"given":"Theodora","family":"Anagnostou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-2300","authenticated-orcid":false,"given":"Zhi-Zhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2938-922X","authenticated-orcid":false,"given":"Daniel P.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-4562","authenticated-orcid":false,"given":"Xinyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-5526","authenticated-orcid":false,"given":"Joshua C.","family":"Pritchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Villasboas","family":"Bisneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy L.","family":"Price-Troska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Mondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-6758","authenticated-orcid":false,"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"1911_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1411087","volume":"372","author":"SM Ansell","year":"2015","unstructured":"Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma. N Engl J Med. 2015;372:311\u20139.","journal-title":"N Engl J Med"},{"key":"1911_CR2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1182\/blood.2019000324","volume":"134","author":"R Chen","year":"2019","unstructured":"Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, et al. Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087. Blood. 2019;134:1144\u201353.","journal-title":"Blood"},{"key":"1911_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1200\/JCO.18.00766","volume":"37","author":"SM Ansell","year":"2019","unstructured":"Ansell SM, Minnema MC, Johnson P, Timmerman JM, Armand P, Shipp MA, et al. Nivolumab for relapsed\/refractory diffuse large B-cell lymphoma in patients ineligible for or having failed autologous transplantation: a single-arm, phase II study. J Clin Oncol. 2019;37:481\u20139.","journal-title":"J Clin Oncol"},{"key":"1911_CR4","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","volume":"34","author":"AM Lesokhin","year":"2016","unstructured":"Lesokhin AM, Ansell SM, Armand P, Scott EC, Halwani A, Gutierrez M, et al. Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study. J Clin Oncol. 2016;34:2698\u2013704.","journal-title":"J Clin Oncol"},{"key":"1911_CR5","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1182\/blood-2017-02-765685","volume":"129","author":"W Ding","year":"2017","unstructured":"Ding W, LaPlant BR, Call TG, Parikh SA, Leis JF, He R, et al. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017;129:3419\u201327.","journal-title":"Blood"},{"key":"1911_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/08923973.2019.1566925","volume":"41","author":"S Najafi","year":"2019","unstructured":"Najafi S, Mirshafiey A. The role of T helper 17 and regulatory T cells in tumor microenvironment. Immunopharmacol Immunotoxicol. 2019;41:16\u201324.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1911_CR7","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-09-0266","volume":"69","author":"ZZ Yang","year":"2009","unstructured":"Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM. Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin\u2019s lymphoma. Cancer Res. 2009;69:5522\u201330.","journal-title":"Cancer Res"},{"key":"1911_CR8","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1038\/leu.2014.84","volume":"28","author":"ZZ Yang","year":"2014","unstructured":"Yang ZZ, Grote DM, Xiu B, Ziesmer SC, Price-Troska TL, Hodge LS, et al. TGF-beta upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin\u2019s lymphoma. Leukemia. 2014;28:1872\u201384.","journal-title":"Leukemia"},{"key":"1911_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6:e1792.","journal-title":"Cell Death Dis"},{"key":"1911_CR10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI59806","volume":"122","author":"ZZ Yang","year":"2012","unstructured":"Yang ZZ, Grote DM, Ziesmer SC, Niki T, Hirashima M, Novak AJ, et al. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma. J Clin Invest. 2012;122:1271\u201382.","journal-title":"J Clin Invest"},{"key":"1911_CR11","doi-asserted-by":"publisher","first-page":"61425","DOI":"10.18632\/oncotarget.18251","volume":"8","author":"ZZ Yang","year":"2017","unstructured":"Yang ZZ, Kim HJ, Villasboas JC, Chen YP, Price-Troska T, Jalali S, et al. Expression of LAG-3 defines exhaustion of intratumoral PD-1(+) T cells and correlates with poor outcome in follicular lymphoma. Oncotarget. 2017;8:61425\u201339.","journal-title":"Oncotarget"},{"key":"1911_CR12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.2021012386","volume":"139","author":"F Bonfiglio","year":"2022","unstructured":"Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, et al. Genetic and phenotypic attributes of splenic marginal zone lymphoma. Blood. 2022;139:732\u201347.","journal-title":"Blood"},{"key":"1911_CR13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","volume":"187","author":"A Gallimore","year":"1998","unstructured":"Gallimore A, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med. 1998;187:1383\u201393.","journal-title":"J Exp Med"},{"key":"1911_CR14","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","volume":"188","author":"AJ Zajac","year":"1998","unstructured":"Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188:2205\u201313.","journal-title":"J Exp Med"},{"key":"1911_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350\u20134.","journal-title":"Nature"},{"key":"1911_CR16","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4049\/jimmunol.179.3.1979","volume":"179","author":"M D\u2019Souza","year":"2007","unstructured":"D\u2019Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, et al. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol. 2007;179:1979\u201387.","journal-title":"J Immunol"},{"key":"1911_CR17","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"HT Jin","year":"2010","unstructured":"Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA. 2010;107:14733\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1911_CR18","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.4049\/jimmunol.0903478","volume":"184","author":"S Takamura","year":"2010","unstructured":"Takamura S, Tsuji-Kawahara S, Yagita H, Akiba H, Sakamoto M, Chikaishi T, et al. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors. J Immunol. 2010;184:4696\u2013707.","journal-title":"J Immunol"},{"key":"1911_CR19","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.4049\/jimmunol.0804211","volume":"182","author":"JF Grosso","year":"2009","unstructured":"Grosso JF, Goldberg MV, Getnet D, Bruno TC, Yen HR, Pyle KJ, et al. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. J Immunol. 2009;182:6659\u201369.","journal-title":"J Immunol"},{"key":"1911_CR20","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","volume":"117","author":"Q Zhou","year":"2011","unstructured":"Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, Munn DH, et al. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood. 2011;117:4501\u201310.","journal-title":"Blood"},{"key":"1911_CR21","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1073\/pnas.1003345107","volume":"107","author":"J Matsuzaki","year":"2010","unstructured":"Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, Beck A, Miller A, Tsuji T, et al. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci USA. 2010;107:7875\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1911_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y, et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell. 2014;26:923\u201337.","journal-title":"Cancer Cell"},{"key":"1911_CR23","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1172\/JCI80445","volume":"125","author":"JM Chauvin","year":"2015","unstructured":"Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sander C, et al. TIGIT and PD-1 impair tumor antigen-specific CD8(+) T cells in melanoma patients. J Clin Invest. 2015;125:2046\u201358.","journal-title":"J Clin Invest"},{"key":"1911_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.1","volume":"5","author":"ZZ Yang","year":"2015","unstructured":"Yang ZZ, Grote DM, Ziesmer SC, Xiu B, Novak AJ, Ansell SM. PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival. Blood Cancer J. 2015;5:e281.","journal-title":"Blood Cancer J"},{"key":"1911_CR25","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.celrep.2019.01.085","volume":"26","author":"ZZ Yang","year":"2019","unstructured":"Yang ZZ, Kim HJ, Villasboas JC, Price-Troska T, Jalali S, Wu H, et al. Mass cytometry analysis reveals that specific intratumoral CD4(+) T cell subsets correlate with patient survival in follicular lymphoma. Cell Rep. 2019;26:2178\u20132193.e2173.","journal-title":"Cell Rep"},{"key":"1911_CR26","first-page":"Unit10 17","volume":"Chapter 10","author":"N Kotecha","year":"2010","unstructured":"Kotecha N, Krutzik PO, Irish JM. Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom. 2010;Chapter 10:Unit10 17.","journal-title":"Curr Protoc Cytom"},{"key":"1911_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.12688\/f1000research.11622.1","volume":"6","author":"M Nowicka","year":"2017","unstructured":"Nowicka M, Krieg C, Crowell HL, Weber LM, Hartmann FJ, Guglietta S, et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Res. 2017;6:748.","journal-title":"F1000Res"},{"key":"1911_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.immuni.2018.04.026","volume":"48","author":"B Bengsch","year":"2018","unstructured":"Bengsch B, Ohtani T, Khan O, Setty M, Manne S, O\u2019Brien S, et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity. 2018;48:1029\u20131045.e1025.","journal-title":"Immunity"},{"key":"1911_CR29","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1200\/JCO.2013.51.5866","volume":"32","author":"MJ Maurer","year":"2014","unstructured":"Maurer MJ, Ghesquieres H, Jais JP, Witzig TE, Haioun C, Thompson CA, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32:1066\u201373.","journal-title":"J Clin Oncol"},{"key":"1911_CR30","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1182\/blood-2014-03-563445","volume":"124","author":"S Audia","year":"2014","unstructured":"Audia S, Rossato M, Santegoets K, Spijkers S, Wichers C, Bekker C, et al. Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia. Blood. 2014;124:2858\u201366.","journal-title":"Blood"},{"key":"1911_CR31","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/leu.2011.301","volume":"26","author":"P Ame-Thomas","year":"2012","unstructured":"Ame-Thomas P, Le Priol J, Yssel H, Caron G, Pangault C, Jean R, et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells. Leukemia. 2012;26:1053\u201363.","journal-title":"Leukemia"},{"key":"1911_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.56.1","volume":"56","author":"T Sugimoto","year":"2016","unstructured":"Sugimoto T, Watanabe T. Follicular lymphoma: the role of the tumor microenvironment in prognosis. J Clin Exp Hematop. 2016;56:1\u201319.","journal-title":"J Clin Exp Hematop"},{"key":"1911_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2016.11.002","volume":"77","author":"S Audia","year":"2017","unstructured":"Audia S, Rossato M, Trad M, Samson M, Santegoets K, Gautheron A, et al. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia. J Autoimmun. 2017;77:89\u201395.","journal-title":"J Autoimmun"},{"key":"1911_CR34","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3389\/fimmu.2019.01915","volume":"10","author":"J Zhao","year":"2019","unstructured":"Zhao J, Shi J, Qu M, Zhao X, Wang H, Huang M, et al. Hyperactive follicular helper T cells contribute to dysregulated humoral immunity in patients with liver cirrhosis. Front Immunol. 2019;10:1915.","journal-title":"Front Immunol"},{"key":"1911_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13000-018-0750-8","volume":"13","author":"K Wickenden","year":"2018","unstructured":"Wickenden K, Nawaz N, Mamand S, Kotecha D, Wilson AL, Wagner SD, et al. PD1(hi) cells associate with clusters of proliferating B-cells in marginal zone lymphoma. Diagn Pathol. 2018;13:74.","journal-title":"Diagn Pathol"},{"key":"1911_CR36","doi-asserted-by":"crossref","unstructured":"Tang X, Yang ZZ, Kim HJ, Anagnostou T, Yu Y, Wu X, et al. Phenotype, function and clinical significance of CD26+ and CD161+ Tregs in splenic marginal zone lymphoma. Clin Cancer Res. 2022;28:4322\u201335.","DOI":"10.1158\/1078-0432.CCR-22-0977"},{"key":"1911_CR37","doi-asserted-by":"publisher","first-page":"e0148044","DOI":"10.1371\/journal.pone.0148044","volume":"11","author":"T Lu","year":"2016","unstructured":"Lu T, Yu S, Liu Y, Yin C, Ye J, Liu Z, et al. Aberrant circulating Th17 cells in patients with B-cell non-hodgkin\u2019s lymphoma. PLoS One. 2016;11:e0148044.","journal-title":"PLoS One"},{"key":"1911_CR38","first-page":"7957","volume":"14","author":"I Hus","year":"2017","unstructured":"Hus I, Bojarska-Junak A, Kaminska M, Dobrzynska-Rutkowska A, Szatan K, Szymczyk A, et al. Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin\u2019s lymphoma. Oncol Lett. 2017;14:7957\u201364.","journal-title":"Oncol Lett"},{"key":"1911_CR39","doi-asserted-by":"publisher","first-page":"3753081","DOI":"10.1155\/2018\/3753081","volume":"2018","author":"M Liang","year":"2018","unstructured":"Liang M, Liwen Z, Yun Z, Yanbo D, Jianping C. The imbalance between Foxp3(+)Tregs and Th1\/Th17\/Th22 cells in patients with newly diagnosed autoimmune hepatitis. J Immunol Res. 2018;2018:3753081.","journal-title":"J Immunol Res"},{"key":"1911_CR40","first-page":"193","volume":"37","author":"Z Bai","year":"2020","unstructured":"Bai Z, Li Z, Guan T, Wang L, Wang J, Wu S, et al. Primary gastric diffuse large B-cell lymphoma: prognostic factors in the immuno-oncology therapeutics era. Turk J Haematol. 2020;37:193\u2013202.","journal-title":"Turk J Haematol"},{"key":"1911_CR41","doi-asserted-by":"publisher","first-page":"919446","DOI":"10.3389\/fcimb.2022.919446","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Liu X, Qin S, Ruan G, Lu A, Zhang J, et al. A novel prognostic score including the CD4\/CD8 for AIDS-related lymphoma. Front Cell Infect Microbiol. 2022;12:919446.","journal-title":"Front Cell Infect Microbiol"},{"key":"1911_CR42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.molcel.2020.02.013","volume":"77","author":"X He","year":"2020","unstructured":"He X, Xu C. PD-1: a driver or passenger of T cell exhaustion? Mol Cell. 2020;77:930\u20131.","journal-title":"Mol Cell"},{"key":"1911_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott DW, Gascoyne RD. The tumour microenvironment in B cell lymphomas. Nat Rev Cancer. 2014;14:517\u201334.","journal-title":"Nat Rev Cancer"},{"key":"1911_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3324\/haematol.2015.139493","volume":"101","author":"NH Fowler","year":"2016","unstructured":"Fowler NH, Cheah CY, Gascoyne RD, Gribben J, Neelapu SS, Ghia P, et al. Role of the tumor microenvironment in mature B-cell lymphoid malignancies. Haematologica. 2016;101:531\u201340.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01911-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T10:02:43Z","timestamp":1688378563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01911-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-01911-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2106183\/v1","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}